Dana-Farber Cancer Institute

https://www.dana-farber.org/

 

Dana-Farber Cancer Institute
Avatar

Lynch Syndrome and Gynecologic Cancer Risk (and Risk Reduction)

By Dana-Farber Cancer Institute FEATURING Marcela G. del Carmen
By Dana-Farber Cancer Institute FEATURING Marcela G. del Carmen
84 views
January 5, 2019
1 Comment
Login to view comments. Click here to Login

Featured Video

06:27
Johnson & Johnson

Challenges to Navigate in Locally Advanced or Metastatic EGFR+ NSCLC

Feat. M. Socinski, D. Waterhouse

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba
Gynecologic
07:23
SGO 2023 Conference Coverage on VuMedi

SGO 2023 Phase 1 Trial of Botensilimab + Balstilimab in Patients Wit…

Feat. B. Bockorny
33:45
Dana-Farber Cancer Institute

Lynch Syndrome and Gynecologic Cancer Risk (and Risk Reduction)

Feat. M. del Carmen